TNF inhibitor treatment is associated with a lower risk of hand osteoarthritis progression in rheumatoid arthritis patients after 10 years

Author(s):: Loef, M. (0000-0003-4301-8350); Kroon, F.P.B.; Bergstra, S.A. (0000-0002-7136-5248); Pol, J.A. van der; Lems, W.F.; Kerstens, P.J.S.M.; Allaart, C.F.; Kloppenburg, M.

Published: 2018
Publication type: Article / Letter to editor

biologic therapieshandosteoarthritisosteophyterheumatoid arthritis

Date issued: 2018-11-30
Language: English
Is part of: Rheumatology (2018), Vol. 57, no. 11, p. 1917-1924
hdl: 1887/78042
doi: 10.1093/rheumatology/key016